ﺑﺪﯾﻦ ﻭﺳﯿﻠﻪ "ﻓﺮﺍﺧﻮﺍﻥ ﮔﺮﻧﺖ ﻣﺸﺘﺮﮎ ﻣﺆﺳﺴﻪ ﻧﯿﻤﺎﺩ ﺑﺎ ﺳﺎﺯﻣﺎﻥ ﭘﮋﻭﻫﺶ ﻫﺎﯼ ﻋﻠﻤﯽ ﻭ ﻓﻨﺎﻭﺭﯼ ﺗﺮﮐﯿﻪ ")TÜBİTAK(ﺭﺍ ﺑﻪ ﺍﻃﻼﻉ ﻣﯽ ﺭﺳﺎﻧﺪ. ﻣﺘﻦ ﮐﺎﻣﻞ ﺍﯾﻦ ﻓﺮﺍﺧﻮﺍﻥ ﺩﺭ ﻭﺑﮕﺎﻩ ﻣﺆﺳﺴﻪ ﻣﻠﯽ ﺗﻮﺳﻌﻪ ﺗﺤﻘﯿﻘﺎﺕ ﻋﻠﻮﻡ ﭘﺰﺷﮑﯽ ﺍﯾﺮﺍﻥ ﺑﻪ ﻧﺸﺎﻧﯽ http://nimad.ac.ir ﺩﺭ ﺑﺨﺶ ﮔﺮﻧﺖ ﻫﺎ ﺍﺭﺍﯾﻪ ﺷﺪﻩ ﺍﺳﺖ . ﻫﻤﭽﻨﯿﻦ ﺍﺯ ﺗﺎﺭﯾﺦ 25/01/1403 ﺳﺎﻣﺎﻧﻪ ﺟﻬﺖ ﺑﺎﺭﮔﺰﺍﺭﯼ ﺍﻃﻼﻋﺎﺕ ﺑﺮﺍﯼ ﻣﺘﻘﺎﺿﯿﺎﻥ ﺑﺎﺯ ﻣﯽ ﺑﺎﺷﺪ.

 

ﺍﯾﻦ ﻓﺮﺍﺧﻮﺍﻥ ﺑﻪ ﻣﻨﻈﻮﺭ ﺣﻤﺎﯾﺖ ﺍﺯ ﭘﮋﻭﻫﺶ ﻫﺎﯼ ﻣﺸﺘﺮﮎ ﺍﯾﺮﺍﻥ ﻭ ﺗﺮﮐﯿﻪ ﺗﻨﻈﯿﻢ ﺷﺪﻩ ﺍﺳﺖ ﻭ ﺣﻀﻮﺭ ﯾﮏ ﻣﺤﻘﻖ ﺍﺯ ﺗﺮﮐﯿﻪ ﻭ ﯾﮏ ﻣﺤﻘﻖ ﺍﺯ ﺍﯾﺮﺍﻥ ﺑﻪ ﻋﻨﻮﺍﻥ ﻣﺤﻘﻖ ﺍﺻﻠﯽ (PI) ﺿﺮﻭﺭﺕ ﺩﺍﺭﺩ. ﻻﺯﻡ ﺑﻪ ﺫﮐﺮ ﺍﺳﺖ ﻓﺮﺍﺧﻮﺍﻥ ﻣﺆﺳﺴﻪ ﻧﯿﻤﺎﺩ ﻣﺤﺪﻭﺩ ﺑﻪ ﻣﺤﻘﻘﺎﻥ ﻭ ﺍﻋﻀﺎﯼ ﻫﯿﺎﺕ ﻋﻠﻤﯽ ﺷﺎﻏﻞ ﺩﺭ ﺩﺍﻧﺸﮕﺎﻩ ﻫﺎ، ﭘﮋﻭﻫﺸﮕﺎﻩ ﻫﺎ ﻭ ﻣﻮﺳﺴﺎﺕ ﺁﻣﻮﺯﺷﯽ ﯾﺎ ﺗﺤﻘﯿﻘﺎﺗﯽ ﻭﺍﺑﺴﺘﻪ ﺑﻪ ﻭﺯﺍﺭﺕ ﺑﻬﺪﺍﺷﺖ ﻭ ﺩﺭﻣﺎﻥ ﻋﻠﻮﻡ ﭘﺰﺷﮑﯽ )ﺩﺍﺭﺍﯼ ﭘﺮﻭﻓﺎﯾﻞ ﺩﺭ ﺳﺎﻣﺎﻧﻪ (https://isid.research.ac.ir ﻣﯿﺒﺎﺷﺪ.

 

ﻣﻬﻠﺖ ﺍﺭﺳﺎﻝ ﺩﺭﺧﻮﺍﺳﺖ ﺑﺮﺍﯼ ﻣﺤﻘﻘﺎﻥ ﺍﯾﺮﺍﻧﯽ: 25 ﺧﺮﺩﺍﺩ 1403

 ﻣﻬﻠﺖ ﺍﺭﺳﺎﻝ ﺩﺭﺧﻮﺍﺳﺖ ﺑﺮﺍﯼ ﻣﺤﻘﻘﺎﻥ ﺗﺮﮐﯿﻪ: 14 ﮊﻭﺋﻦ 2024

 

ﺯﻣﯿﻨﻪ  ﻫﺎﯼ ﻣﻮﺿﻮﻋﯽ ﻭ ﮔﺮﺍﯾﺶ  ﻫﺎﯼ ﻣﻮﺭﺩ ﺣﻤﺎﯾﺖ ﻣﺆﺳﺴﻪ ﻧﯿﻤﺎﺩ:

 

1-Development of rapid diagnostic methods for viruses, especially those with pandemic potential.

2-Innovative techniques to combat antibiotic resistance.

3-Preventive research aimed at reducing the burden of diabetes.

4-New methods for early detection of cancer.

5-Preventive strategies to reduce the prevalence of mental illness

ﻣﯿﺰﺍﻥ ﺣﻤﺎﯾﺖ ﻣﺎﻟﯽ: ﺳﻘﻒ ﺣﻤﺎﯾﺖ ﻣﺆﺳﺴﻪ ﻧﯿﻤﺎﺩ ﺍﺯ ﺍﯾﻦ ﻃﺮﺡ   ﻫﺎﯼ ﺑﺮﮔﺰﯾﺪﻩ ﻣﻌﺎﺩﻝ 500 ﻣﯿﻠﯿﻮﻥ ﺗﻮﻣﺎﻥ )ﻭ ﺣﺪﺍﮐﺜﺮ ٣ ﻃﺮﺡ( ﻣﯿﺒﺎﺷﺪ.

ﺳﻘﻒ ﺣﻤﺎﯾﺖ ﺗﻮﺑﯿﺘﺎﮎ ﻣﻌﺎﺩﻝ ﺳﯿﺼﺪ ﻫﺰﺍﺭ ﻟﯿﺮ ﺗﺮﮐﯿﻪ ﺍﺳﺖ.